Navegar por término MeSH "Xenograft Model Antitumor Assays"

Mostrando ítems 1-5 de 5

AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors

2013- Rios García, Marcos; Foretz, M.; Viollet, B.; Prieto González, Angel; Fraga Rodríguez, Máximo Francisco; [et al.]
Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer

2020- Alonso Alconada, Lorena; De La Fuente González, Alexandre; Santacana, M.; Ferreirós López, Alba; López López, Rafael; [et al.]
Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma

2015- González-Gómez, P.; Crecente-Campo, J.; Zahonero, C.; De La Fuente Freire, María; Hernández-Laín, A.; [et al.]
OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine

2020- López-Cortés, Andrés; Paz-Y-Miño, César; Guerrero, Santiago; Cabrera-Andrade, Alejandro; Barigye, Stephen J; [et al.]
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models

2019- Gomez-Miragaya, J.; Moran, S.; Calleja-Cervantes, M. E.; Collado-Sole, A.; Pare, L.; [et al.]